{{Rsnum
|rsid=6127983
|Gene=BMP7
|Chromosome=20
|position=57249419
|Orientation=plus
|GMAF=0.3526
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=BMP7
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 57.5 | 35.4
| HCB | 6.6 | 30.1 | 63.2
| JPT | 7.1 | 34.8 | 58.0
| YRI | 21.4 | 54.5 | 24.1
| ASW | 17.5 | 56.1 | 26.3
| CHB | 6.6 | 30.1 | 63.2
| CHD | 9.4 | 28.3 | 62.3
| GIH | 13.9 | 46.5 | 39.6
| LWK | 10.2 | 43.5 | 46.3
| MEX | 20.7 | 48.3 | 31.0
| MKK | 12.4 | 55.6 | 32.0
| TSI | 9.8 | 51.0 | 39.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6127983
|Name_s=
|Gene_s=BMP7
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00004. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109329
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6127983
|overall_frequency_n=39
|overall_frequency_d=110
|overall_frequency=0.354545
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=35
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}